Home Menten AI

Menten AI

In operation
Seed Round Financing
Early-Stage Drug Discovery Companies
Basic
Enterprise Profile

Basic Information

Menten AI, Inc.'s mission is to use machine learning and quantum computing to create the next generation of protein-based drugs.Menten AI, Inc. is an early-stage drug discovery company that develops technology surpassing current computational methods, making it possible to design entirely new protein therapies from scratch—opening up an unexplored area for drug discovery. It has created the first protein design algorithm for current and near-term quantum computers and has designed the world's first protein on a quantum computer. We are supported by investments from some of the world’s leading venture capitalists.
Menten AI, Inc.
SanFrancisco,California,United States of America
less than 15 people
August 24, 2018
info@menten.ai

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Machine Learning Protein Technology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs AI+Pharmaceuticals